ViaDerma, Inc. Stock Price - VDRM

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$65.99
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$30.00
SMALL CAP PRO
Monthly Subscription
for only
$43.59
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Viaderma, Inc. (PC) VDRM Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.00093 -6.03% 0.0145 0.01645 0.0145 0.0151 0.01543 11:34:56
Bid Price Ask Price Spread Spread % News
0.0146 0.0152 0.0006 3.95% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
64 2,057,956 $ 0.0155 $ 31.82k 16.65M 0.0012 - 0.07
Last Trade Time Type Quantity Stock Price Currency
11:30:32 50,000 $0.01 USD

Viaderma, Inc. (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 5.55M 340.71M - - 222.34M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
76.91k 0.02% $ - 0.00% - -

more financials information »

Viaderma, Inc. (PC) News

Historical VDRM Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.0190.0190.0120.00003M14M9M-0.0045-23.68%
1 Month0.027050.03380.0120.00003M26M11M-0.01255-46.40%
3 Months0.01190.0690.00850.00003M62M17M0.002621.85%
6 Months0.00230.0690.001270.00000138M16M0.0122530.43%
1 Year0.0060.0690.00120.00000138M8M0.0085141.67%
3 Years0.01220.510.001150.00000138M3M0.002318.85%
5 Years0.060.510.00090.00000138M3M-0.0455-75.83%

Viaderma, Inc. (PC) Description

ViaDerma, Inc. is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development. The Company manufactures and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company?s products are normally applied topically using a patent-pending delivery system technology created by Dr. Phillips and Dr. Chris Ayo Otiko. Presently, the products are used within the OTC drug market, i.e. non-prescription. However, the Company believes the delivery system can be used for the prescription medication market as well not only for topical prescription medications but also to turn certain oral medications into topically based medications. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.